Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

United Therapeutic (UTHR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,082,425
  • Shares Outstanding, K 43,540
  • Annual Sales, $ 1,725 M
  • Annual Income, $ 417,900 K
  • 36-Month Beta 1.32
  • Price/Sales 2.99
  • Price/Cash Flow 9.75
  • Price/Book 2.14

Price Performance

See More
Period Period Low Period High Performance
1-Month
102.70 +13.41%
on 05/29/18
118.59 -1.79%
on 06/18/18
+11.39 (+10.84%)
since 05/22/18
3-Month
100.57 +15.81%
on 05/11/18
118.93 -2.07%
on 04/05/18
+8.05 (+7.42%)
since 03/22/18
52-Week
100.57 +15.81%
on 05/11/18
152.55 -23.65%
on 01/03/18
-15.23 (-11.56%)
since 06/22/17

Most Recent Stories

More News
SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of SteadyMed Ltd. - STDY

Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating SteadyMed Ltd. ("SteadyMed"...

STDY : 4.53 (+0.56%)
UTHR : 116.47 (-0.22%)
United Therapeutics And XVIVO Perfusion Announce Collaboration To Reduce Organ Shortage Through Expansion Of Organ Evaluation Service

United Therapeutics Corporation (Nasdaq: UTHR) and XVIVO Perfusion, Inc., a subsidiary of XVIVO Perfusion AB (STO: XVIVO), today announced that the use of XVIVO's ex-vivo lung perfusion (EVLP) technology...

XVIPF : 12.7600 (+25.59%)
UTHR : 116.47 (-0.22%)
TG Therapeutics and Three Additional Stocks Under Scanner in the Biotech Space

Stock Research Monitor: TRVN, UTHR, and VNDA

TGTX : 13.70 (-1.08%)
TRVN : 1.63 (-2.40%)
UTHR : 116.47 (-0.22%)
United Therapeutics (UTHR) Up 3.9% Since Earnings Report: Can It Continue?

United Therapeutics (UTHR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

UTHR : 116.47 (-0.22%)
Pharma Stock Roundup: Mixed Q1 for MRK, PFE, FDA Nod for Kymriah's 2nd Indication

Earnings are in focus this week with Pfizer (PFE) and Merck (MRK) delivering mixed Q1 numbers. Novartis gains FDA approval for the second indication of its CAR-T therapy, Kymriah.

JNJ : 122.84 (+1.14%)
MRK : 61.47 (+0.47%)
AGN : 173.42 (+0.54%)
NVS : 75.06 (+1.46%)
ABBV : 93.49 (-2.16%)
PFE : 36.51 (+0.58%)
UTHR : 116.47 (-0.22%)
Report: Exploring Fundamental Drivers Behind Reliance Steel & Aluminum, Goldman Sachs BDC, IBERIABANK, Federal Signal, United Therapeutics, and LifePoint Health -- New Horizons, Emerging Trends, and Upcoming Developments

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Reliance Steel & Aluminum Co....

RS : 93.37 (+1.53%)
IBKC : 79.45 (-1.00%)
FSS : 23.85 (+0.46%)
LPNT : 51.85 (-2.17%)
UTHR : 116.47 (-0.22%)
GSBD : 20.91 (+0.05%)
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces an Investigation of SteadyMed Ltd.- STDY

BALA CYNWYD, PA / ACCESSWIRE / May 3, 2018 / Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of SteadyMed Ltd. ("SteadyMed" or "the...

STDY : 4.53 (+0.56%)
UTHR : 116.47 (-0.22%)
United Therapeutics (UTHR) Q1 Earnings Rise, Sales Drop Q/Q

United Therapeutics' (UTHR) earnings per share rise in the first quarter. Sales drop sequentially due to unfavorable timing of distributor orders. Shares sink almost 7%.

STDY : 4.53 (+0.56%)
LLY : 85.92 (-0.17%)
MDT : 86.81 (+0.59%)
UTHR : 116.47 (-0.22%)
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Regarding Whether the Sale of SteadyMed Ltd. to United Therapeutics Corporation is Fair to Shareholders

The following statement is being issued by Levi & Korsinsky, LLP:

STDY : 4.53 (+0.56%)
UTHR : 116.47 (-0.22%)
Blog Exposure - United Therapeutics Acquired SteadyMed for Approximately $216 Million

LONDON, UK / ACCESSWIRE / May 02, 2018 / Active-Investors.com has just released a free research report on United Therapeutics Corp. (NASDAQ: ). If you want access to this report all you need to do is sign...

UTHR : 116.47 (-0.22%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators mostly agree with the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade UTHR with:

Business Summary

United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of innovative products to address the unmet medical needs of patients with chronic and life-threatening conditions. United Therapeutics (UT) has an overarching commitment to environmental sustainability....

See More

Key Turning Points

2nd Resistance Point 119.33
1st Resistance Point 117.90
Last Price 116.47
1st Support Level 115.28
2nd Support Level 114.10

See More

52-Week High 152.55
Fibonacci 61.8% 132.69
Fibonacci 50% 126.56
Fibonacci 38.2% 120.43
Last Price 116.47
52-Week Low 100.57

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar